HQH
Abrdn Healthcare Investors
Price Chart
Latest Quote
$21.03
| Previous Close | $20.48 |
| Open | $20.60 |
| Day High | $21.24 |
| Day Low | $20.57 |
| Volume | 333,206 |
Stock Information
| Quarterly Dividend / Yield | $2.32 / 11.33% |
| Shares Outstanding | 57.19M |
| Quarterly Dividend Yield | 11.33% |
| Quarterly Dividend | $2.32 |
| Revenue | $5.54M |
| Net Income | $252.77M |
| Sector | Financial Services |
| Industry | Asset Management |
| Market Cap | $1.20B |
| P/E Ratio | 4.70 |
| EPS (TTM) | $4.47 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Sales | $5.54M |
| Income | $252.77M |
| Book/sh | $19.88 |
Financial Ratios
| Quick Ratio | 0.94 |
| Current Ratio | 1.02 |
Returns & Margins
| ROA | -0.35% |
| ROE | 24.21% |
| Gross Margin | 100.00% |
| Operating Margin | -125.50% |
| Profit Margin | 4561.32% |
Ownership
| Insider Ownership | 0.00% |
| Institutional Ownership | 23.02% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 217.04 |
| P/B | 1.06 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $19.55 |
| SMA50 | $19.38 |
| SMA200 | $17.96 |
| RSI | 81.10 |
| ATR | 0.4314 |
| Short Ratio | 0.98 |
| Volatility | 0.76 |
| Rel Volume | 2.13 |
Performance History
| Week | +7.57% |
| Month | +8.01% |
| Quarter | +21.66% |
| 6 Months | +17.98% |
| YTD | +18.60% |
| Year | +57.27% |
| 3 Years | +75.19% |
| 5 Years | +43.18% |
| 10 Years | +148.05% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $21.03 | 333,206 |
| 2026-06-23 | $20.48 | 203,900 |
| 2026-06-22 | $20.22 | 169,500 |
| 2026-06-18 | $20.19 | 130,600 |
| 2026-06-17 | $19.90 | 146,000 |
| 2026-06-16 | $19.55 | 98,000 |
| 2026-06-15 | $19.52 | 178,500 |
| 2026-06-12 | $19.35 | 76,300 |
| 2026-06-11 | $19.04 | 130,500 |
| 2026-06-10 | $18.77 | 90,600 |
| 2026-06-09 | $18.90 | 130,800 |
| 2026-06-08 | $18.77 | 130,600 |
| 2026-06-05 | $19.12 | 185,700 |
| 2026-06-04 | $19.26 | 192,200 |
| 2026-06-03 | $18.99 | 265,100 |
| 2026-06-02 | $19.16 | 209,800 |
| 2026-06-01 | $19.70 | 109,200 |
| 2026-05-29 | $19.99 | 109,700 |
| 2026-05-28 | $19.65 | 119,100 |
| 2026-05-27 | $19.45 | 124,300 |
| 2026-05-26 | $19.36 | 197,700 |
About Abrdn Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
đ° Latest News
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $99,813,475 | $186,456,510 | $58,118,274 | $-192,264,875 |
| Operating Revenue | $99,813,475 | $186,456,510 | $58,118,274 | $-192,264,875 |
| Expenses | ||||
| Operating Expense | $1,200,194 | $1,509,879 | $1,783,446 | $1,964,498 |
| Other Operating Expenses | $55,726 | $58,677 | $547,371 | $564,145 |
| General And Administrative Expense | $1,144,468 | $1,451,202 | $1,236,075 | $1,400,353 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Net Interest Income | $1,001,370 | $2,018,602 | $620,013 | $112,314 |
| Interest Income | $1,001,370 | $2,018,602 | $620,013 | $112,314 |
| Normalized Income | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Net Income From Continuing And Discontinued Operation | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Net Income Common Stockholders | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Net Income | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Net Income Including Noncontrolling Interests | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Net Income Continuous Operations | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Pretax Income | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Per Share | ||||
| Diluted EPS | - | $3.53 | $1.09 | $-4.28 |
| Basic EPS | - | $3.53 | $1.09 | $-4.28 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Diluted NI Availto Com Stockholders | $98,613,281 | $184,946,631 | $56,334,828 | $-194,229,373 |
| Gain On Sale Of Security | $26,043,115 | $47,763,436 | $90,152,826 | $66,375,590 |
| Selling General And Administration | $1,144,468 | $1,451,202 | $1,236,075 | $1,400,353 |
| Diluted Average Shares | - | $52,392,813 | $51,683,328 | $45,380,695 |
| Basic Average Shares | - | $52,392,813 | $51,683,328 | $45,380,695 |
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,093,828,807 | $1,059,595,952 | $931,342,991 | $916,564,588 |
| Total Assets | $1,097,257,729 | $1,060,991,051 | $932,491,693 | $926,275,365 |
| Investmentin Financial Assets | $1,094,629,717 | $1,060,387,169 | $925,586,542 | $923,357,715 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $1,079,022,372 | $1,025,955,632 | $892,849,542 | $923,357,715 |
| Prepaid Assets | $75,341 | $94,401 | $50,801 | $49,104 |
| Receivables | $2,538,553 | $495,366 | $6,853,864 | $2,867,482 |
| Taxes Receivable | $13,787 | $13,787 | - | - |
| Cash And Cash Equivalents | $59 | $56 | $214 | $792 |
| Cash Financial | $59 | $56 | $214 | $792 |
| Cash Cash Equivalents And Federal Funds Sold | $59 | $56 | $214 | $792 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,428,922 | $1,395,099 | $1,148,702 | $9,710,777 |
| Derivative Product Liabilities | $1,092,664 | $263,645 | - | - |
| Payables | $2,105,095 | $949,019 | - | $8,495,653 |
| Other Payable | $892,085 | $949,019 | - | $8,495,653 |
| Accounts Payable | $1,213,010 | - | - | - |
| Equity | ||||
| Common Stock Equity | $1,093,828,807 | $1,059,595,952 | $931,342,991 | $916,564,588 |
| Total Equity Gross Minority Interest | $1,093,828,807 | $1,059,595,952 | $931,342,991 | $916,564,588 |
| Stockholders Equity | $1,093,828,807 | $1,059,595,952 | $931,342,991 | $916,564,588 |
| Retained Earnings | $101,585,801 | $117,945,997 | $5,971,880 | $24,820,360 |
| Other | ||||
| Ordinary Shares Number | $55,510,323 | $52,129,892 | $49,442,016 | $47,343,726 |
| Share Issued | $55,510,323 | $52,129,892 | $49,442,016 | $47,343,726 |
| Tangible Book Value | $1,093,828,807 | $1,059,595,952 | $931,342,991 | $916,564,588 |
| Additional Paid In Capital | $991,687,903 | $941,128,656 | $924,876,691 | $891,270,791 |
| Capital Stock | $555,103 | $521,299 | $494,420 | $473,437 |
| Common Stock | $555,103 | $521,299 | $494,420 | $473,437 |
| Investments And Advances | $1,094,629,717 | $1,060,387,169 | $925,586,542 | $923,357,715 |
| Available For Sale Securities | $15,607,345 | $34,431,537 | $32,737,000 | - |